Strategies for the elimination of taeniasis/cysticercosis

被引:44
作者
Garcia, Hector H. [1 ]
Gonzalez, Armando E.
Del Brutto, Oscar H.
Tsang, Victor C. W.
Llanos-Zavalaga, Fernando
Gonzalvez, Guillermo
Romero, Jaime
Gilman, Robert H.
机构
[1] Univ Peruana Cayetano Heredia, Dept Microbiol, Sch Sci, Lima, Peru
[2] Univ Peruana Cayetano Heredia, Proyecto Eliminac Cisticercosis, Lima, Peru
[3] Inst Nacl Ciencias Neurol, Cysticercosis Unit, Lima, Peru
[4] Univ Nacl Mayor San Marcos, Sch Vet Med, Lima 14, Peru
[5] Johns Hopkins Univ, Bloomberg Sch Hyg & Publ Hlth, Dept Int Hlth, Baltimore, MD USA
[6] Hosp Clin Kennedy, Guayaquil, Ecuador
[7] Natl Ctr Infect Dis, Parasit Dis Branch, Div Parasit Dis, Ctr Dis Control & Prevent, Atlanta, GA 30333 USA
[8] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Lima, Peru
基金
英国惠康基金;
关键词
taeniasis; cysticercosis; computed tomography;
D O I
10.1016/j.jns.2007.06.039
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Advances in the field of neurocysticercosis continue to shape our understanding of the disease and our efforts to control it. Several attempts have been made to eradicate the disease with active interventions such as changing domestic pig-raising practices, mass chemotherapy of porcine cysticercosis and taeniasis, selective detection and treatment of taeniasis, and community health education. Moreover, ongoing progress in the diagnosis of taeniasis and the development of a porcine vaccine against cysticercosis in Australia, Mexico and Peru has yielded at least one effective vaccine that is currently available. Thus far, however, attempted interventions have only been successful in temporarily disrupting transmission of the disease. Controlled data on the efficacy and acceptability of the different interventions is urgently needed to provide a baseline schematic for intervention which could later be tailored to each particular endemic scenario. (c) 2007 Published by Elsevier B.V.
引用
收藏
页码:153 / 157
页数:5
相关论文
共 45 条
[1]   Mass chemotherapy for intestinal Taenia solium infection: effect on prevalence in humans and pigs [J].
Allan, JC ;
VelasquezTohom, M ;
Fletes, C ;
TorresAlvarez, R ;
LopezVirula, G ;
Yurrita, P ;
deAlfaro, HS ;
Rivera, A ;
GarciaNoval, J .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1997, 91 (05) :595-598
[2]   Immunodiagnostic tools for taeniasis [J].
Allan, JC ;
Wilkins, PP ;
Tsang, VCW ;
Craig, PS .
ACTA TROPICA, 2003, 87 (01) :87-93
[3]  
Bernat JL, 1999, HASTINGS CENT REP, V29, P5
[4]  
CRUZ M, 1989, B WORLD HEALTH ORGAN, V67, P401
[5]   Therapeutic capacity of the synthetic peptide-based vaccine against Taenia solium cysticercosis in pigs [J].
de Aluja, AS ;
Villalobos, NM ;
Nava, G ;
Toledo, A ;
Martínez, JJ ;
Plancarte, A ;
Rodarte, LF ;
Fragoso, G ;
Sciutto, E .
VACCINE, 2005, 23 (31) :4062-4069
[6]  
Del Brutto OH, 2005, EPILEPSIA, V46, P583, DOI 10.1111/j.0013-9580.2005.36504.x
[7]   Immunodiagnostic approaches for detecting Taenia solium [J].
Dorny, P ;
Brandt, J ;
Geerts, S .
TRENDS IN PARASITOLOGY, 2004, 20 (06) :259-260
[8]   Survival of Taenia solium cysticerci in carcasses of pigs kept at 4 C [J].
Fan, PC ;
Ma, YX ;
Kuo, CH ;
Chung, WC .
JOURNAL OF PARASITOLOGY, 1998, 84 (01) :174-175
[9]   Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens [J].
Flisser, A ;
Gauci, CG ;
Zoli, A ;
Martinez-Ocaña, J ;
Garza-Rodriguez, A ;
Dominguez-Alpizar, JL ;
Maravilla, P ;
Rodriguez-Canul, R ;
Avila, G ;
Aguilar-Vega, L ;
Kyngdon, C ;
Geerts, S ;
Lightowlers, MW .
INFECTION AND IMMUNITY, 2004, 72 (09) :5292-5297
[10]   NEUROLOGICAL SYMPTOMS IN OCCULT NEUROCYSTICERCOSIS AFTER SINGLE TAENIACIDAL DOSE OF PRAZIQUANTEL [J].
FLISSER, A ;
MADRAZO, I ;
PLANCARTE, A ;
SCHANTZ, P ;
ALLAN, J ;
CRAIG, P ;
SARTI, E .
LANCET, 1993, 342 (8873) :748-748